AIP
TARS icon

Ameritas Investment Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Ameritas Investment Partners’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
3,801
+529
+16% +$33.8K 0.01% 1290
2026
Q1 		$230K Hold
3,272
– – 0.01% 1192
2025
Q4 		$268K Hold
3,272
– – 0.01% 1086
2025
Q3 		$194K Sell
3,272
-576
-15% -$28.4K 0.01% 1254
2025
Q2 		$156K Hold
3,848
– – ﹤0.01% 1461
2025
Q1 		$198K Hold
3,848
– – 0.01% 1270
2024
Q4 		$213K Buy
3,848
+244
+7% +$11.1K 0.01% 1283
2024
Q3 		$119K Hold
3,604
– – ﹤0.01% 1676
2024
Q2 		$98K Buy
3,604
+634
+21% +$21.3K ﹤0.01% 1741
2024
Q1 		$108K Hold
2,970
– – ﹤0.01% 1687
2023
Q4 		$60.1K Buy
2,970
+1,023
+53% +$17.1K ﹤0.01% 2052
2023
Q3 		$34.6K Hold
1,947
– – ﹤0.01% 2290
2023
Q2 		$35.2K Buy
1,947
+587
+43% +$9.33K ﹤0.01% 2248
2023
Q1 		$17.1K Hold
1,360
– – ﹤0.01% 2526
2022
Q4 		$21.3K Hold
1,360
– – ﹤0.01% 2539
2022
Q3 		$23K Hold
1,360
– – ﹤0.01% 2465
2022
Q2 		$19K Buy
1,360
+845
+164% +$12.7K ﹤0.01% 2575
2022
Q1 		$9K Hold
515
– – ﹤0.01% 2837
2021
Q4 		$12K Hold
515
– – ﹤0.01% 2846
2021
Q3 		$11K Hold
515
– – ﹤0.01% 2920
2021
Q2 		$15K Hold
515
– – ﹤0.01% 2854
2021
Q1 		$17K Hold
515
– – ﹤0.01% 2637
2020
Q4 		$21K Buy
+515
New +$14.7K ﹤0.01% 2450

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ameritas Investment Partners's TARS Position: Q2 2026 in Review

Ameritas Investment Partners increased its Tarsus Pharmaceuticals (TARS) stake by 16% in Q2 2026, buying an estimated $33.8K and bringing the position to 3,801 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #1290.

Ameritas Investment Partners first reported a position in TARS in Q4 2020 and has held it in 23 quarters since. The position peaked at $268K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Ameritas Investment Partners held 3,801 shares of Tarsus Pharmaceuticals worth $239K as of Q2 2026.
  • Ameritas Investment Partners bought 529 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $33.8K.
  • Tarsus Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1290 holding.
  • Ameritas Investment Partners first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Ameritas Investment Partners's Tarsus Pharmaceuticals position peaked at $268K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.